CT scan

New Guidelines on Men with Erectile Dysfunction and Cardiac Health Published in the Journal of Sexual Medicine Concludes PDE-5 Inhibitors are Still Safe for the Cardiovascular System

Retrieved on: 
Thursday, January 4, 2024

Their summary and guidelines have now been published in the Journal of Sexual Medicine.

Key Points: 
  • Their summary and guidelines have now been published in the Journal of Sexual Medicine.
  • They determined that PDE-5 inhibitors are still safe for the cardiovascular system.
  • The conference was funded by an unrestricted grant from Sanofi to readdress the cardiovascular workup of men presenting with ED and the cardiovascular safety of the phosphodiesterase-5 (PDE-5) inhibitors for treating ED.
  • Patients with ED should be characterized as low-risk, intermediate (or indeterminable), or high-risk of developing a cardiac event with sexual activity.

Respiratory Disease Testing Market Size & Trends Analysis 2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 28, 2023

The "Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030
    The market is driven by the rising prevalence of respiratory diseases.
  • Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.
  • These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

Stratasys Partners with Siemens Healthineers in Landmark Research Project to Advance Medical Imaging

Retrieved on: 
Monday, November 27, 2023

Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing and additive manufacturing solutions, today announced it has partnered with Siemens Healthineers to carry out a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography (CT) imaging.

Key Points: 
  • Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing and additive manufacturing solutions, today announced it has partnered with Siemens Healthineers to carry out a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography (CT) imaging.
  • (Photo: Business Wire)
    A critical tool in medical imaging and an almost universal resource in hospitals worldwide, CT phantoms are specialized devices used to evaluate and ensure the performance of CT scanners.
  • “The current limitations of imaging phantoms have been a longstanding challenge for the radiology community,” said Erez Ben Zvi, Vice President Medical at Stratasys.
  • “Knowledge gained from this project provides a breakthrough in medical imaging that will open up new avenues for uses when it comes to 3D printing and imaging,” said Lampros Theodorakis, Head of Computed Tomography Product & Clinical Marketing at Siemens Healthineers.

CMS Reporting, Image Quality, and QC Features Unveiled at RSNA 2023

Retrieved on: 
Monday, November 27, 2023

CMS eCQM Report: Enhance your diagnostic capabilities with our in-depth evaluation and reporting, focusing on excessive radiation dose or inadequate image quality in adult diagnostic computed tomography (CT).

Key Points: 
  • CMS eCQM Report: Enhance your diagnostic capabilities with our in-depth evaluation and reporting, focusing on excessive radiation dose or inadequate image quality in adult diagnostic computed tomography (CT).
  • This cutting-edge approach ensures a superior understanding of image resolution to provide critical image details.
  • This critical analysis offers a detailed insight into the granularity of fluctuations in your images affecting image quality.
  • Automatic QC Monitoring: Automatically determine whether daily QC for CT has been performed, eliminating manual checks and streamlining your workflow.

United Imaging Showcases Pioneering Advances and Reinforces U.S. Growth at RSNA 2023

Retrieved on: 
Tuesday, November 21, 2023

HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023.

Key Points: 
  • HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023.
  • Highlighting this growth at RSNA 2023, United Imaging will feature the uMR Jupiter 5T (510k pending; not available commercially in the U.S.), a revolutionary whole-body 5T MRI system.
  • In recognition of exceptional scientific contributions, United Imaging takes pride in celebrating Lingzhi (Lance) Hu, Ph.D, a Vice President at United Imaging Healthcare America, who will be honored as a 2023 Distinguished Investigator at RSNA.
  • RSNA attendees are invited to experience the future of medical imaging at Booth #4100, where United Imaging continues to bridge innovation and patient care through state-of-the-art technologies.

ConcertAI's TeraRecon, Integrates Clinical and Generative AI, Supporting Clinical Research and Advancing Clinical Care Solutions at #RSNA23

Retrieved on: 
Monday, November 20, 2023

CAMBRIDGE, Mass., Nov. 20, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI leader, recently unveiled first-in-category capabilities in advanced visualization, AI, and expansions to its AI partner ecosystem to enhance research capabilities and support complex clinical study workflows. These solutions will provide researchers with enhanced data analysis tools for in-depth study, contributing to more informed care strategies that can improve patient outcomes.

Key Points: 
  • New solutions empower clinicians and research teams with AI orchestration, model development, visualization, and multi-modal data management to power clinical research, clinical trials, and patient care strategies.
  • These solutions will provide researchers with enhanced data analysis tools for in-depth study, contributing to more informed care strategies that can improve patient outcomes.
  • Leveraging ConcertAI's Eureka Life Science AI Platform, powered by TeraRecon, MSKCC will drive advancements in multi-modal AI workflows, using clinical and radiological imaging data.
  • Our joint vision is clear: advance the utility and efficacy of Clinical AI in oncology research, extending its benefits to more patients and institutions in the future.

TSA is prepared for more travelers at airport security checkpoints, expects this holiday travel season to be the busiest ever

Retrieved on: 
Monday, November 13, 2023

Historically, the three busiest travel days are the Tuesday and Wednesday prior to Thanksgiving and the Sunday afterward.

Key Points: 
  • Historically, the three busiest travel days are the Tuesday and Wednesday prior to Thanksgiving and the Sunday afterward.
  • In 2023, we have already seen seven of the top 10 busiest travel days in TSA's history," said TSA Administrator David Pekoske.
  • "We are ready for the anticipated volumes and are working closely with our airline and airport partners to make sure we are prepared for this busy holiday travel season.
  • I am grateful for our dedicated employees who continue to remain vigilant and focused on the mission during this holiday travel season and beyond."

Generational Equity Advises Alloyweld Inspection in its Sale to Acuren Inspection

Retrieved on: 
Friday, October 20, 2023

Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client Alloyweld Inspection to Acuren Inspection, Inc.

Key Points: 
  • Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client Alloyweld Inspection to Acuren Inspection, Inc.
  • Located in Bensenville and Elgin, Illinois, Alloyweld Inspection (Alloyweld) serves critical industries, including aerospace, electronics, medical devices, and forensics.
  • Alloyweld was one of the world’s first organizations to achieve National Aerospace & Defense Contractors Accreditation Program (NADCP) certification in CR and DR digital x-ray inspection.
  • Acuren shares many of the same values and is the perfect partner for the Alloyweld family,” said LePage.

ConcertAI's TeraRecon Showcases New Clinical and AI Solutions Designed to Enhance Treatment Planning for Structural Heart Patients at TCT 2023

Retrieved on: 
Monday, October 23, 2023

NEW strategic partnership to offer FEops HEARTguide™ Digital Twin solution for an elevated structural heart experience for LAA closure procedures.

Key Points: 
  • NEW strategic partnership to offer FEops HEARTguide™ Digital Twin solution for an elevated structural heart experience for LAA closure procedures.
  • LIVE physician-led presentations on advancing cardiac care utilizing Intuition 4.7, and FEops solutions.
  • Cardiology Suite applications on the Eureka Clinical AI platform are FDA and CE-cleared with additional regional clearances.
  • FEops HEARTguide is a unique cloud-based procedure planning solution in the structural heart, based on Digital Twin technologies.

Hemet Global Medical Center Voted “Best Hospital” in the Inland Empire by Press-Enterprise Readers for 2023

Retrieved on: 
Tuesday, October 17, 2023

ORANGE, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Hemet Global Medical Center (“HGMC”), a KPC Health hospital, has been voted “Best Hospital” in the Inland Empire for 2023 by Press-Enterprise readers.

Key Points: 
  • ORANGE, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Hemet Global Medical Center (“HGMC”), a KPC Health hospital, has been voted “Best Hospital” in the Inland Empire for 2023 by Press-Enterprise readers.
  • The distinguished honor is part of the Press-Enterprise’s 28th Annual “Best of Inland Empire” Readers’ Choice awards for local businesses.
  • “Prior to KPC Health’s acquisition of Hemet Global Medical Center, this was a hospital on the brink of bankruptcy that many believed could not be saved,” said Dr. Kali P. Chaudhuri, Founder and Chairman of the KPC Group.
  • KPC Health’s current system of hospitals includes seven full-service acute care hospitals located throughout southern California, including Orange County Global Medical Center, Chapman Global Medical Center, Anaheim Global Medical Center, South Coast Global Medical Center, Hemet Global Medical Center, Menifee Global Medical Center, and Victor Valley Global Medical Center.